CClinicalTrials.gg
CompletedNCT03993145Updated May 12, 2021

Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus ('Mom's Healthy Heart')

An interventional study of Web-based lifestyle intervention in Pre-Eclampsia and Gestational Diabetes, sponsored by Norwegian University of Science and Technology. Completed at 2 sites in Norway. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-12.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The aim of this pilot intervention study is to develop and test a tailored web-based lifestyle modification program for women with recent preeclampsia or gestational diabetes. Women will start the study 3-15 months postpartum. After obtaining written informed consent and confirmation of eligibility criteria, eligible women will be included in the pilot study using a single arm study design (all women will be assigned to the lifestyle intervention program). Participants will be provided access to a web-based lifestyle intervention program with personalized coaching from a registered dietician.

02

Conditions studied

  • Pre-Eclampsia
  • Gestational Diabetes

Keywords

  • Mentoring
  • Healthy life style
  • Postpartum Period
03

In context

Diabetes, Gestational

842 studies on the registry are indexed under Diabetes, Gestational; 198 are open to participants now.

This study's enrollment of 44 is below the median of 110 across 550 interventional studies indexed under Diabetes, Gestational.

Browse Diabetes, Gestational studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of preeclampsia or gestational diabetes in recent pregnancy, confirmed by medical record review
  • capable to speak and read Norwegian
  • access to internet enabled mobile devices that use either iOS or Android operating systems

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of chronic hypertension or diabetes mellitus
  • current use of blood pressure lowering medication
  • medication known to affect glucose tolerance
  • active self-reported eating disorder
  • history of heart disease, stroke or kidney disease
  • history of gastric bypass or bowel surgery resulting in malabsorption
  • active medical problems that would interfere with following the diet, or with changes in blood pressure and/or weight
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Web-based lifestyle intervention

    participants will be provided access to web-based lifestyle intervention program with personalized coaching from a clinical dietician

    Behavioral: Web-based lifestyle intervention

Interventions

  • BehavioralWeb-based lifestyle intervention

    Lifestyle intervention program including educational modules on diet and physical activity with visual and audio. Phone conversation with the clinical dietician at week 1, week 3, week 6, week 12 and month 6 (completion of the study).

06

What researchers measure

Primary outcomes

  1. Recruitment

    Proportion of eligible patients enrolled in the study

    Time frame: baseline

  2. Retention

    Proportion of participants kept in the study

    Time frame: 3 months

  3. Retention

    Proportion of participants kept in the study

    Time frame: 6 months

  4. Adherence

    Proportion of participants following study program (visiting the study's website and having scheduled phone conversations with the dietician)

    Time frame: 3 months

  5. Adherence

    Proportion of participants following study program (visiting the study's website and having scheduled phone conversations with the dietician)

    Time frame: 6 months

Secondary outcomes

  1. Adherence to Norwegian food-based dietary guidelines

    We will use the NORDIET food frequency questionnaire to measure adherence to the qualitative recommendations of the Norwegian food-based dietary guidelines (FBDG) (Henriksen et al. 2018). We will measure the proportion of participants complying with the Norwegian FBDG.

    Time frame: 3 months

  2. Adherence to Norwegian food-based dietary guidelines

    We will use the NORDIET food frequency questionnaire to measure adherence to the qualitative recommendations of the Norwegian food-based dietary guidelines (Henriksen et al. 2018). We will measure the proportion of participants complying with the Norwegian FBDG.

    Time frame: 6 months

  3. Changes in physical activity levels

    Changes in physical activity levels assessed by physical activity sensors (two tri-axial accelerometers, AX3 Axivity, one on the thigh and second on lower back)

    Time frame: baseline, 3 months

  4. Changes in physical activity levels

    Changes in physical activity levels assessed by physical activity sensors (two tri-axial accelerometers, AX3 Axivity, one on the thigh and second on lower back)

    Time frame: baseline, 6 months

  5. Changes in body weight

    Changes in body weight measured in kilograms

    Time frame: Baseline, 3 months

  6. Changes in body weight

    Changes in body weight measured in kilograms

    Time frame: Baseline, 6 months

  7. Changes in blood pressure

    Changes in blood pressure in mmHg (measured three times at 1-minute intervals after the participant has come to rest, using an automatic oscillometric method with cuff size adjusted to arm circumference)

    Time frame: Baseline, 3 months

  8. Changes in blood pressure

    Changes in blood pressure in mmHg (measured three times at 1-minute intervals after the participant has come to rest, using an automatic oscillometric method with cuff size adjusted to arm circumference)

    Time frame: Baseline, 6 months

  9. Changes in total cholesterol

    Changes in total cholesterol measured in mmol/l in non fasting blood samples

    Time frame: Baseline, 3 months

  10. Changes in total cholesterol

    Changes in total cholesterol measured in mmol/l in non fasting blood samples

    Time frame: Baseline, 6 months

  11. Changes in HbA1c

    Changes in HbA1c measured in mmol/l in non fasting blood samples

    Time frame: Baseline, 3 months

  12. Changes in HbA1c

    Changes in HbA1c measured in mmol/l in non fasting blood samples

    Time frame: Baseline, 6 months

Other outcomes

  1. Participant satisfaction

    Participants will complete qualitative surveys and participate in semi-structured interviews to measure their satisfaction with the intervention program.

    Time frame: 9 months

07

Study locations

2 sites
  • Levanger sykehus
    Levanger, Norway
  • St Olavs Hospital
    Trondheim, Norway
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03993145
Lead sponsor
Norwegian University of Science and Technology
Collaborators
Harvard Medical School (HMS and HSDM), University of Oslo, Helse Nord-Trøndelag HF, St. Olavs Hospital
Responsible party
Sponsor
First posted
Jun 20, 2019
Start date
Feb 7, 2020
Primary completion
May 4, 2021
Completion
May 4, 2021
Last update
May 12, 2021

Study contacts

Siri Forsmo, md prof
study director · Norwegian University of Science and Technology NTNU

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion